Perspective Therapeutics Inc. (CATX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Perspective Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Perspective Therapeutics Inc. (CATX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $136M. It trades at $1.25, up 5.04% today. Its overall quality score is 40 out of 100, ranked against the whole US market. 11 analysts' average target of $10.18 implies +714.4% from today's price. Kronos AI's 30-day forecast is +162.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.18 |
| Low – high | $4.00 – $15.00 |
| Analysts | 11 |
| Upside to average | +714.4% |
Kronos AI 30-day forecast
| Expected close | $3.12 (+162.1%) |
| Likely range | +154.3% … +171.0% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 41 |
| Solvency | 61 |
| Growth | 18 |
| Overall | 40 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator